Novartis trial suspensions seen as limited financial impact
Citi analysts said Novartis’s decision to suspend several cell-therapy clinical trials after three patient deaths is expected to have limited financial impact, pending further updates.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.